Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

18.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 27.50
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 138.07m
  • Volume: 136,420
  • Market Cap: £24.85m
  • RiskGrade: 594
  • Beta: 0.97

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 18.00p
Change Today -0.50p
% Change -2.70 %
52 Week High 27.50
52 Week Low 11.25
Volume 136,420
Shares Issued 138.07m
Market Cap £24.85m
Beta 0.97
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Price Trend
27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 30-Jan-2026

Time Volume / Share Price
13:05 6 @ 17.00p
13:04 50,000 @ 17.30p
11:20 6,000 @ 17.40p
10:48 1,382 @ 17.45p
10:48 1,382 @ 17.45p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page